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The pab genes for para-aminobenzoic acid (pABA) biosynthesis in Lactococcus lactis were identified and
characterized. In L. lactis NZ9000, only two of the three genes needed for pABA production were initially found.
No gene coding for 4-amino-4-deoxychorismate lyase (pabC) was initially annotated, but detailed analysis
revealed that pabC was fused with the 3 end of the gene coding for chorismate synthetase component II (pabB).
Therefore, we hypothesize that all three enzyme activities needed for pABA production are present in L. lactis,
allowing for the production of pABA. Indeed, the overexpression of the pABA gene cluster in L. lactis resulted
in elevated pABA pools, demonstrating that the genes are involved in the biosynthesis of pABA. Moreover, a
pABA knockout (KO) strain lacking pabA and pabBC was constructed and shown to be unable to produce folate
when cultivated in the absence of pABA. This KO strain was unable to grow in chemically defined medium
lacking glycine, serine, nucleobases/nucleosides, and pABA. The addition of the purine guanine, adenine,
xanthine, or inosine restored growth but not the production of folate. This suggests that, in the presence of
purines, folate is not essential for the growth of L. lactis. It also shows that folate is not strictly required for
the pyrimidine biosynthesis pathway. L. lactis strain NZ7024, overexpressing both the folate and pABA gene
clusters, was found to produce 2.7 mg of folate/liter per optical density unit at 600 nm when the strain was
grown on chemically defined medium without pABA. This is in sharp contrast to L. lactis strains overexpressing
only one of the two gene clusters. Therefore, we conclude that elevated folate levels can be obtained only by the
overexpression of folate combined with the overexpression of the pABA biosynthesis gene cluster, suggesting
the need for a balanced carbon flux through the folate and pABA biosynthesis pathway in the wild-type strain.
Many plants and bacteria have the ability to produce folate.
Folate is essential for most animals, including humans, and
insufficient intake of folate may lead to physiological disorders,
such as anemia and neural tube defects in newborns (20).
Among elderly people, folate deficiency may also lead to men-
tal disorders such as psychiatric syndromes and decreased cog-
nitive performance (6, 13). It is also assumed that folate has
protective properties against cardiovascular diseases and a few
types of cancer (4, 5, 20). Metabolic engineering of fermenta-
tive microbes can be used to produce food products with ele-
vated folate contents.
Folate biosynthesis proceeds via the conversion of GTP in
seven consecutive steps to the biologically active cofactor tet-
rahydrofolate (THF). Two condensation reactions take place
in the biosynthesis pathway of THF. The first is the condensa-
tion of para-aminobenzoic acid (pABA) with 2-amino-4-hy-
droxy-6-hydroxymethyl-7,8-dihydropteridine to produce dihy-
dropteroate. The second is the reaction of glutamate with
dihydropteroate to form dihydrofolate (8) (Fig. 1). pABA itself
is synthesized from the pentose phosphate pathway; in this
pathway, D-erythrose 4-phosphate is condensed with phos-
phoenolpyruvate to ultimately lead to chorismate (Fig. 1).
Chorismate serves as a branching point for the synthesis of the
aromatic amino acids (tryptophan, phenylalanine, tyrosine)
and pABA (21). In Escherichia coli, chorismate is converted via
chorismate synthetase components I and II (PabB and PabA,
EC 6.3.5.8) into 4-amino-4-deoxychorismate. Subsequently,
pyruvate is cleaved by 4-amino-4-deoxychorismate lyase
(PabC, EC 4.1.3.38), to result in pABA (10, 26) (Fig. 1). pABA
knockout (KO) strains of E. coli are unable to grow in the
absence of pABA or folate in a minimal medium (9, 15).
Without pABA, no THF can be produced, and THF is essen-
tial as the donor and acceptor of one-carbon groups (i.e.,
methyl, formyl, methenyl, and methylene) in the biosynthesis
of purines and pyrimidines, formyl-methionyl tRNAfMet, and
some amino acids (24, 37). Interestingly, it was found that
Streptococcus faecalis R, incapable of producing folate, was
able to grow on medium without folate. Growth was achieved
in a chemically defined medium (CDM) supplemented with
medium components which require folate for biosynthesis, i.e.,
methionine, serine, thymine, adenine, and guanine (33).
An extensive genetic metabolic engineering approach has
been applied to the folate biosynthesis genes in Lactococcus
lactis (38). The overexpression of the folate gene cluster (folB
folKE folP folQ folC) resulted in a folate-overproducing strain,
but only when pABA was added to the medium.
In this paper, we describe the involvement of the pABA
genes in the production of folate in L. lactis. First, the genes
coding for pABA biosynthesis were characterized. Second, a
pABA KO strain was constructed; in this strain, folate produc-
tion and growth performance were analyzed in the presence
and absence of pABA, glycine, serine, and nucleobases/nucleo-
sides (guanine, adenine, uracil, xanthine, inosine, thymidine,
and orotic acid). Finally, we analyzed the effect of overexpres-
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sion of the folate biosynthesis genes combined with overex-
pression of the pABA biosynthesis genes on folate pools.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and cultivations. The bacterial strains,
plasmids, and primers used in this study are listed in Table 1. The Lactococcus
lactis NZ9000-derived strains were grown at 30°C on CDM (25, 27, 29) and M17
broth and agar (43). CDM contains the following medium components: 3 g/liter
K2HPO4, 3 g/liter KH2PO4, 1 g/liter sodium acetate, 0.6 g/liter ammonium
citrate, 11 g/liter glucose · 1H2O, 0.5 g/liter ascorbic acid, 0.25 g/liter L-tyrosine,
0.001 g/liter Ca-(D)-()-pantothenate, 0.0025 g/liter D-biotin, 0.001 g/liter 6,8-
thiotic acid, 0.001 g/liter nicotinic acid, 0.005 g/liter pyridoxamine HCl, 0.002
g/liter pyridoxine HCl, 0.001 g/liter riboflavin, 0.001 g/liter thiamine HCl,
0.001 g/liter vitamin B12, 0.005 g/liter inosine, 0.005 g/liter thymidine, 0.005 g/liter
orotic acid, 0.2 g/liter MgCl2 · 6H2O, 0.05 g/liter CaCl2 · 2H2O, 0.016
g/liter MnCl2 · 4H2O, 0.003 g/liter FeCl3 · 6H2O, 0.005 g/liter FeCl2 · 4H2O, 0.005
g/liter ZnSO4 · 7H2O, 0.0025 g/liter CoSO4 · 7H2O, 0.0025 g/liter CuSO4 · 5H2O,
0.0025 g/liter (NH4)6Mo7O24 · 4H2O, 0.24 g/liter alanine, 0.125 g/liter arginine,
0.42 g/liter aspartic acid, 0.13 g/liter cysteine-HCl, 0.50 g/liter glutamic acid, 0.175
g/liter glycine, 0.15 g/liter histidine, 0.21 g/liter isoleucine, 0.475 g/liter leucine,
0.44 g/liter lysine, 0.125 g/liter methionine, 0.275 g/liter phenylalanine, 0.675
g/liter proline, 0.34 g/liter serine, 0.225 g/liter threonine, 0.05 g/liter tryptophan,
0.325 g/liter valine, 0.01 g/liter guanine, 0.01 g/liter adenine, 0.01 g/liter uracil,
and 0.01 g/liter xanthine. CDM was used to evaluate the growth rate and the
pools of pABA and folate. M17 broth and M17 agar were used for the construc-
tion of the engineered strains. The CDM described here may lack nucleobases,
nucleosides, glycine, serine, and pABA. When these components were added
separately, the concentrations as described above were used. Spent medium was
made by growth of the NZ9000pABA strain on CDM lacking nucleobases,
nucleosides, glycine, serine, and pABA, and the spent medium was filter steril-
ized with a 0.22-m filter. The pH of the spent medium was adjusted to the
original pH of 6.5, and 0.5% additional glucose was added; afterwards, this
medium was filter sterilized again. The spent medium was subsequently used as
the growth medium to test specific nutrient requirements of L. lactis
NZ9000pABA. The E. coli DH5 strain (47), used for the construction of the
pABA KO strain, was grown at 37°C in TY medium plates (30). Growth rates for
the L. lactis strains were determined in 96-well microtiter plates by measuring
turbidity at 600 nm using the Spectra Max384 spectrophotometer (Molecular
Devices). To select and maintain the plasmid, we used the following antibiotics:
chloramphenicol at 10 mg/liter, tetracycline at 10 mg/liter, and erythromycin at
10 mg/liter for L. lactis and at 50 mg/liter for E. coli.
Genetic constructs and DNA methods. E. coli DH5 was transformed by the
CaCl2 procedure (32) and L. lactis strains by electroporation (7). PCRs for the
construction of KO and overproduction vectors were performed with Pfx poly-
merase (Invitrogen, Breda, The Netherlands). Taq polymerase (Promega Bio-
tech, Roosendaal, The Netherlands) was used for the PCRs to check the lengths
of inserts. L. lactis genomic DNA was isolated using established procedures (18,
45), and plasmid DNA was isolated using Jetstar columns (Genomed GmbH,
Bad Deynhausen, Germany). All restriction enzymes but Ecl136II (Fermentas
UAB, Vilnius, Lithuania) were purchased from Invitrogen. The preintegration
vector for the inactivation of the pabA-pabBC gene cluster was constructed by
using the Cre-lox system (17). The sequence with the up- and downstream
regions of the pABA gene cluster of L. lactis MG1363 was used for amplification
by PCR. This sequence appears in the GenBank nucleotide sequence library
under accession number AM406671. The first amplified linear fragment of DNA
is 1,359 base pairs in length (the pabA fragment); the second fragment, with a
length of 550 base pairs, is designated the pabBC fragment. The pabA fragment
contains the upstream region of pabA, annotated as a surface protein gene, and
ends with the first 15 base pairs of pabA. For the PCR, the forward primer
FLLSURFPRxho-F (the sequence was modified to introduce an XhoI digestion
sequence [Table 1]) and the reverse primer RLLpabA15nucl-R were used (Table
1). The second fragment, the pabBC fragment, contains the final 15 base pairs of
pabBC, the intergenic regions, and 346 base pairs of the neighboring open
reading frame yneH. The forward primer FLLpabBC15nucl-F and reverse primer
RLLyneHBgl2-R (the sequence was modified to introduce a BglII digestion
sequence [Table 1]) were used for the PCR. After amplification of the two PCR
fragments, plasmid pNZ5319 was digested with PmeI and XhoI and the pabA
fragment was digested with XhoI. Subsequently, the digested pabA fragment was
ligated into the PmeI/XhoI-digested pNZ5319 vector with T4 DNA ligase (In-
vitrogen) and was then cloned in the E. coli DH5 strain. Transformants with the
expected insert length were selected on TY agar plates containing erythromycin.
The selected colonies were checked for the proper digestion profile. The result-
ing plasmid, designated pNZ7027, was isolated and used for Ecl136II and BglII
digestion, and the pabBC fragment was digested by BglII and subsequently
ligated into the Ecl136II/BglII-digested pNZ7027 vector with T4 ligase. E. coli
DH5 was subsequently transformed with the ligation mix. After 2 days of
growth, a few colonies were picked and cultivated. From these strains, the pABA
KO integration vector (pNZ7028) was isolated, checked for the presence of the
pabBC fragment by PCR, and digested to check for restriction profiles. The
pNZ7028 pABA KO vector was transferred to competent cells of the L. lactis
NZ9000 strain. The transformed cells were selected on M17 plates containing
chloramphenicol. To select colonies with the double-crossover genotype, erythro-
mycin-sensitive colonies were selected by colony streaking on plates containing
FIG. 1. Biosynthesis pathway of pABA and folate, showing the conversion of GTP into THF, the route for pABA biosynthesis from chorismate,
and the incorporation of pABA into THF.
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chloramphenicol with or without erythromycin. Erythromycin-sensitive L. lactis
colonies were then analyzed by PCR to confirm the double-crossover genotype.
The analysis was performed by using the forward primer FLLsurfpRupstream
and the reverse primer 66doRCS85 to amplify the upstream region of the surface
protein gene up to the chloramphenicol resistance gene. The downstream region
of yneH was also checked by PCR. For this purpose, the forward primer
FpRB36catF3 and the reverse primer RLLyneHupstream were used to amplify
the chloramphenicol resistance gene in the downstream region of yneH. A clean
deletion mutant was obtained by the addition of a plasmid which contained the
resolvase gene to recombine the two lox loci on both sides of the chloramphen-
icol resistance gene. The plasmid for the recombination of the two lox sites in L.
lactis was constructed as follows. The resolvase gene was obtained by digestion of
plasmid pNZ5348 (17) with HindIII and KpnI. Subsequently, plasmid pGHOST8
(2) was digested with SmaI. Afterwards, both digested DNA fragments were
mixed and used for T4 DNA ligation. After the ligation, SmaI digestion was
performed to prevent self-ligation. Then the ligated DNA fragment was trans-
ferred to L. lactis NZ9000 and tetracycline-resistant strains were selected and
checked for the correct restriction profile. The vector with the proper orientation
was named pNZ5327. Growth experiments with the transformants containing
pNZ5327 were performed at 20°C. The clean KO was made by transferring
pNZ5327 into competent L. lactis NZ9000pABA. Tetracycline- and chloram-
phenicol-resistant colonies were picked up and grown on M17 at 42°C for 1 h;
thereafter, the cells were further cultivated at 30°C. This temperature shift leads
to the instability of the maintenance of pNZ5327. After prolonged incubation for
approximately 24 h, the vector is lost. The clean KO genotype of strain
NZ9000pABA was tested by PCR using the forward primer FLLsurfpRup-
stream and the reverse primer RLLyneHupstream. A single L. lactis colony
lacking the pABA gene cluster was selected, cultivated, and stored as a glycerol
stock. This strain was designated NZ9000pABA.
Overproduction of pABA by using the pNZ8148 and the pIL253 vector. For the
overproduction of pABA and complementation of strain NZ9000pABA, two
nisin-inducible vectors were constructed. One vector was based on pNZ8148 (16)
and the other one on pIL253 (35). First, the pNZ8148-derived vector was con-
structed; the L. lactis pABA biosynthesis gene cluster pabA-pabBC was amplified
by PCR using the forward primer lclpabAsphI2 and the reverse primer lclpabB/
CxbaI. The lclpabAsphI2 and lclpabB/CxbaI primers were modified in their
sequences to introduce two restriction sites. The forward primer contained an
SphI site, and the reverse primer contained an XbaI restriction site (Table 1).
The vector pNZ8148 was digested with XbaI and SphI, and the same digestion
was performed on the amplified DNA of the pABA gene cluster. Subsequently,
both fragments were mixed, ligated with T4 DNA ligase, and transferred to the
L. lactis NZ9000 wild-type strain and to the NZ9000pABA strain. The resulting
vector was named pNZ7020. For the second overproduction vector based on
pIL253, plasmid pNZ7020 (containing the pABA gene cluster behind the nisin
promoter) was used as a template for a PCR using forward primer pnisF and
reverse primer pabBCrevR. The PCR product, containing the nisin promoter
and the pABA gene cluster, was mixed with a SmaI-digested pIL253 vector and
subsequently ligated using T4 DNA ligase. After ligation, the mixture was again
TABLE 1. List of strains, constructed plasmids, and primers used
Strain, plasmid, or primer Relevant feature(s)a Source orreference
Strains
E. coli DH5 Cloning host 47
L. lactis NZ9000 MG1363 pepN::nisRK, cloning host 16
L. lactis NZ7024 L. lactis NZ9000 containing pNZ7019 and pNZ7023 This study
L. lactis NZ9000pABA L. lactis NZ9000 lacking pabA and pabBC This study
L. casei ATCC 7469 L. casei, the indicator strain for the folate microbiological assay 11
Plasmidsb
pNZ8148 Cmr; empty vector, nisin promoter 16
pNZ7020 Cmr pNZ8148 derivative, containing the pabA and pabBC genes of L. lactis NZ9000 This study
pNZ7021 Cmr pNZ8148 derivative, nisin promoter replaced by pepN promoter This study
pNZ7022 Cmr RpNZ7021 derivative, containing the pabA and pabBC genes of L. lactis NZ9000 This study
pNZ7017 Cmr, pNZ8148 derivative containing folKE of L. lactis 39
pNZ7019 Cmr, pNZ8148 derivative containing the folB, folP, folKE, folQ, and folC gene cluster of L. lactis 46
pNZ5319 Cmr Eryr, double-crossover deletion vector 17
pNZ7027 Cmr Eryr, pNZ5319 vector containing a linear PCR product; surface protein gene upstream of
pabA, including the final 15 bases pairs of pabA
This study
pNZ7028 Cmr Eryr, pNZ7028 containing a linear PCR product and the final 15 base pairs of pabBC up to
346 bp in yneH
This study
pIL253 Eryr 35
pNZ7023 Eryr, pIL253 derivative, containing the nisin promoter along with pabA and the pabBC gene
cluster of L. lactis
This study
pNZ5327 Tetr pGHOST derivative, containing the resolvase gene for recombination of lox sites This study
pNZ5348 Tetr NZ7110 derivative, containing the resolvase gene for recombination of lox sites 17
pGHOST8 Tetr ori(Ts) 2
Primers
FLLSURFPRxho-F CGTTCTCGAGTGATCATATATC
RLLpabA15nucl-R TAAAAGTAATCGCATTTTATC
FLLpabB/C15nucl-F GATGGTATTTCTTAATTATAAAG
RLLyneHbgl2-R GTACGAAGATCTTCATTATTG
FpRB36catF3 CATTACCGAAGTAATCGTTAAAC
RLLyneHupstream CTTTTAAATGTAGCAAAAAC
66doRCS85 GTTTTTTTCTAGTCCAAGCTCACA
FLLSURFPRupstream GTTTTATAAAACATGAAAG
lclpabAsphI2 AGTCGCATGCGAGGAGGATAAAATGCGATTAC
lclpabB/CXbaI CAAGGCTTTTCTAGATTAAGAAATACCATCG
pnisF TAGTCTTATAACTATACTGAC
pabB/CrevR CTAGATTAAGAAATACCATCG
a The XhoI digestion sequence is underlined in the forward primer FLLSURFPRxho-F, as are the BglII digestion sequence in the reverse primer RLLyneHBgl2-R,
the SphI site in the lclpabAsph primer, and the XbaI site in the reverse primer lclpabBCxbaI.
b Where indicated, all pNZ plasmids contain the pSH71 or PWV01 origin of replication.
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digested with SmaI to prevent the self-ligation of pIL253. The ligation mix was
transferred to competent cells of L. lactis NZ9000, NZ9000pABA, and L. lactis
harboring the folate overexpression vector pNZ7019 (46). Transformed cells
capable of growing on erythromycin were selected, checked by PCR for proper
orientation, and further checked by restriction profiling. The resulting vector was
named pNZ7023. L. lactis harboring pNZ7019 and pNZ7023 was designated L.
lactis NZ7024. Cultivation of this strain requires the presence of both chloram-
phenicol and erythromycin.
A pNZ8148 derivative was used for the constitutive overexpression of pABA.
The pNZ8148 vector was first digested using BglII and SphI. The same digestion
was also performed on the pNZ7017 vector (39), thereby excising the constitutive
pepN promoter. The digested pNZ8148 vector and pepN promoter were mixed,
and both fragments were ligated using T4 ligase. Subsequently, the ligation
mixture was added to competent cells of L. lactis NZ9000 for transformation by
electroporation. Transformants capable of growing on M17 plates containing
chloramphenicol were selected and checked for the presence of the vector. The
resulting vector was named pNZ7021. Plasmid pNZ7021 was then isolated from
L. lactis. To construct the vector for constitutive pABA overproduction, first the
pABA gene cluster of L. lactis was amplified using the forward primer lclpabAsphI2
and the reverse primer lclpabB/CxbaI (whose sequences were modified to introduce
an SphI and XbaI digestion sequence [Table 1]). Plasmid pNZ7021 and the PCR
product were digested with SphI and XbaI. These two DNA fragments were
ligated and transferred into electrocompetent cells of L. lactis NZ9000 and
NZ9000pABA. The constructed vector was designated pNZ7022. In addition,
the L. lactis wild-type and NZ9000pABA strains were transformed with
pNZ8148 to deliver experimental control strains.
Folate and pABA analyses. Folate was quantified using a microbiological assay
with Lactobacillus casei ATCC 7469 as the indicator strain. Enzymatic deconju-
gation of polyglutamate tails was part of the sample preparation (11, 40). The
detection limit of the microbiological folate assay was determined to be 2 g/
liter. To analyze folate production in the pABA KO strain grown on CDM
lacking pABA and/or nucleobases/nucleosides, the following concentration step
was employed to detect low folate concentrations. A culture (250 ml) was cen-
trifuged and washed twice with 50 ml wash buffer (100 mM sodium acetate and
1% vitamin C) to prevent oxidation of the folate molecules. The pellet was
resuspended in 5 ml wash buffer and subsequently extracted by bead beating
(three times for 30 s at speed 4 using a FastprepFP120 apparatus [Qbiogene Inc.,
France]). The broken cells were boiled for 3 min. Subsequently, the supernatant
was collected by centrifugation and the centrifugation step was repeated several
times to remove all cell debris. The clear supernatant was finally lyophilized, and
the resulting cell extract was dissolved in 0.5 ml 0.1 M NaOH and was further
used for folate analyses in the microbiological assay.
The pABA production levels were determined using a procedure based on the
high-performance liquid chromatography (HPLC) method described previously
(41, 42). Instead of using an HPLC separation gradient of 75% elution liquid B
(MilliQ plus 1.5% formic acid) and 25% elution liquid C (80% MilliQ–20%
methanol plus 1.5% formic acid), a ratio of 60% elution liquid B to 40% elution
liquid C was used for the proper separation of pABA on the column. For the
pABA standard, 10 mg/liter of pABA was used.
Chemicals. All chemicals were reagent grade and obtained from commercial
sources.
RESULTS
Identification of the pABA genes in L. lactis. The pabC gene,
essential for the conversion of 4-amino-4-deoxychorismate to
pabA, was initially not identified in the genomes of Lactococcus
lactis SK11 and IL-1403 (ERGO database). The pabC gene
could also not be identified in the pABA gene cluster of
MG1363. Nevertheless, strains SK11 and MG1363 were able to
produce folate (41), suggesting that the pABA biosynthesis
pathway is complete in these strains. Interestingly, all three L.
lactis strains contain the pabA and pabB genes, which are
essential for the conversion of chorismate into 4-amino deoxy-
chorismate. To identify the missing pabC gene, the pabB gene
of IL-1403 was compared to all genomes present in the ERGO
database by BLAST P (31) analysis. This revealed that pabB in
Clostridium difficile 630 was very similar to the first part of pabB
in L. lactis IL-1403. However, pabB of L. lactis contains an
additional sequence with a length of 741 base pairs, which is
homologous to pabC of C. difficile 630 (Fig. 2). The pabC of C.
difficile 630 shares homology to known 4-amino deoxychoris-
mate lyases of both E. coli and Bacillus subtilis (10, 36). Based
on this in silico analysis, we conclude that L. lactis contains a
pabBC fusion gene. The BLAST search also revealed that such
pabBC fusion genes are present in both gram-positive and
gram-negative species, such as Streptococcus pyogenes M5 and
Helicobacter pylori J99, respectively (Fig. 2). Based on the L.
lactis MG1363 sequence, we hypothesize that the three L. lactis
strains possess all genes needed for pABA production, which
would be in agreement the observed folate production in the L.
lactis NZ9000 strain, when cultivated in the absence of pABA
(41).
Inactivation of the pabA-pabBC gene cluster. The presence,
activity, and physiological role of the pABA biosynthesis path-
way in L. lactis was evaluated by inactivating the pABA gene
cluster through the construction a double-crossover mutant.
Strain L. lactis NZ9000pABA lacks 98.8% of the pABA gene
cluster. The growth rate, final optical density at 600 nm
(OD600), and total folate pools were determined for the wild-
type strain and strain NZ9000pABA, grown on CDM in the
presence or absence of pABA and nucleobases/nucleosides
(Table 2). The growth rate and final OD600 of strain
NZ9000pABA on medium lacking pABA and nucleobases/
nucleosides are severely impaired, reaching a maximum
growth rate of only 0.02 h1 and a final OD600 of 0.5, which are
much lower than the growth rate of 0.31 h1 and final OD600
of 3.2 for the wild type. The fact that the NZ9000pABA strain
was able to grow poorly but consistently on medium lacking
pABA and nucleobases/nucleosides is somewhat unexpected.
Therefore, we checked whether the CDM contained trace
amounts pABA, folate, glycine, serine, or nucleobases/nucleo-
sides. To test this, the following experiment was conducted.
Strain NZ9000pABA was grown on CDM lacking pABA
FIG. 2. Organization of the pabBC fusion gene in Lactococcus lac-
tis MG1363 compared to those of the pabB (pABA synthetase com-
ponent I) and pabC (4-amino-4-deoxychorismate lyase) genes of Clos-
tridium difficile 630, Lactococcus lactis IL-1403, Streptococcus pyogenes
M5, and Helicobacter pylori J99. The E score for the similarity between
the pabC gene of C. difficile 630 and the pabC part of the L. lactis
IL-1403 pabBC gene upon BLAST P analysis was 1.e7, suggesting
similar functions.
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glycine, serine, and nucleobases/nucleosides until no further
increase in optical density was observed (OD600 of 0.5). The
spent medium of strain NZ9000pABA was filter sterilized
and adjusted to the initial pH, and finally, 0.5% additional
glucose was added. The freshly inoculated NZ9000pABA
strain was unable to grow on the spent medium, even though
glucose and other nutrients were still present in sufficient
amounts. The addition of pABA to the spent medium resulted
in good growth of the KO mutant, showing that the medium
still supports growth. The spent CDM was subsequently sup-
plemented with either adenine, guanine, inosine, or xanthine
(purines); orotic acid, thymidine, or uracil (pyrimidines); gly-
cine/serine; or pABA. Interestingly, the growth of the pABA
KO strain was restored in the presence of the purine nucleo-
bases (adenine, guanine, and xanthine) as well as the purine
nucleoside inosine. The addition of pyrimidines (uracil, thymi-
dine, and orotic acid) as well as the mixture of glycine and
serine did not support the growth of the mutant in the spent
medium (Table 3). The results of this experiment, together
with the data supplied in Table 2, show that, in L. lactis, folate
is essential for purine biosynthesis. The experiments also show
that folate is not strictly required for the pyrimidine biosyn-
thesis pathway. Finally, we conclude that the folate-dependent
interconversion of glycine and serine is not essential for growth
(24, 37).
Folate pools were determined in the wild type and in strain
NZ9000pABA on CDM containing or lacking pABA and
nucleobases/nucleosides (Table 2). Regardless of whether
pABA and nucleobases/nucleosides were added to the me-
dium, wild-type L. lactis accumulated folate pools ranging from
90.3 to 129.9 g/liter. This is consistent with folate pools in L.
lactis strains measured in another study (41). However, the
pABA KO strain was unable to accumulate folate pools when
cultivated on CDM lacking pABA, thereby reaching folate levels
of only 0.05 g/liter. This low level of accumulated folate is pos-
sibly a consequence of the uptake of trace amounts of folate or
folate precursors from the medium (see above). Interestingly, the
growth rate of strain NZ9000pABA was restored by the addition
of nucleobases/nucleosides to the medium, although folate pools
remained very low (0.05 g/liter). The addition of pABA to a
culture of the NZ9000pABA strain boosted folate pools back to
wild-type levels, i.e., approximately 100 g/liter (Table 2). These
experiments suggest that folate production in L. lactis is essential
for growth only when no nucleobases/nucleosides are present in
the medium. In the presence of purines, folate is not essential for
growth.
Effect of pABA overproduction on the folate and pABA pools
in the wild-type and NZ9000pABA strains. The pabA-pabBC
genes for the biosynthesis of pABA were cloned on different
plasmids to determine the impact of pABA overproduction on
the production of folate in the wild-type and NZ9000pABA
strains. Strain NZ9000 and NZ9000pABA were comple-
mented with two nisin-inducible pABA overexpression vectors
(pNZ7020 and pNZ7023) and one constitutive pABA overex-
pression vector (pNZ7022). Folate analysis, performed on
strain NZ9000pABA harboring pNZ7020, showed that pools
were restored to wild-type levels, regardless of whether nisin
was added for induction (data not shown). The folate analyses
performed on the wild-type strain harboring pNZ7020 dis-
played a shift in folate distribution across the intracellular and
extracellular compartment upon induction of expression with
nisin (Fig. 3). The L. lactis wild-type strain harboring the empty
vector pNZ8148 showed no shift in folate distribution upon
induction with nisin, indicating that this shift was caused by the
overproduction of pABA and not by the nisin itself. The shift
in folate distribution was also observed in strain NZ9000 (wild
type) harboring pNZ7022 (constitutive overexpression) and
pNZ7023 (nisin-induced overexpression) as well as in the
NZ9000pABA strain harboring the same pABA overproduc-
tion vectors, pNZ7020, pNZ7022, and pNZ7023 (data not
shown). In none of the strains were increased folate pools
observed. In conclusion, overproduction of pABA did not in-
crease folate production levels, suggesting the need for a bal-
TABLE 2. Growth rates, final OD600 values, and total folate production levels of the wild-type and NZ9000pABA strains grown on CDM
with and without pABA and nucleobases/nucleosides
Presence of
pABA
Presence of
nucleobase/
nucleoside
Wild type NZ9000pABA Mean concn (g/liter) of folate(SD) produced in:
Mean growth rate
(h1) (SD) OD600
Mean growth rate
(h1) (SD) OD600 Wild type NZ9000pABA
  0.31 (0.03) 3.2 0.02 (0.001) 0.5 91.7 (10.5) 0.05 (0.01)a
  0.31 (0.01) 3.3 0.29 (0.03) 3.1 129.9 (7.9) 92.0 (12.3)
  0.32 (0.05) 3.5 0.26 (0.04) 3.3 103.7 (9.6) 0.05 (0.01)a
  0.32 (0.03) 3.5 0.35 (0.06) 3.3 90.3 (16.0) 109.7 (10.3)
a This sample was concentrated 500-fold prior to its addition in the microbiological assay. The actual concentration given in this table is the calculated value based
on analysis of the concentrated sample in the assay.
TABLE 3. Growth of the NZ9000pABA strain on spent medium
without and with supplementation
Medium component(s) added Growthato spent medium
None......................................................................................................
Adenine ................................................................................................
Guanine ................................................................................................
Inosine ..................................................................................................
Xanthine ...............................................................................................
Orotic acid............................................................................................
Thymidine.............................................................................................
Uracil ....................................................................................................
Glycine and serine...............................................................................
pABA ....................................................................................................
All nucleobases/nucleosides ...............................................................
a No growth is expressed as , and growth is expressed as .
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anced carbon flux through the folate and the pABA biosynthe-
sis pathway.
The levels of pABA production in the L. lactis wild type,
the NZ9000pABA strain, and the NZ9000pABA strain
harboring pNZ7020, pNZ7022, and pNZ7023 were quanti-
fied. All strains were cultivated on CDM with nucleobases/
nucleosides in the absence of pABA. The levels of pABA
production were determined by HPLC. The accumulation of
pABA could not be detected in the L. lactis wild-type or
NZ9000pABA strain or in the uninduced NZ9000pABA
strain carrying pNZ7020 or pNZ7023. However, after nisin
induction, the NZ9000pABA strains harboring pNZ7020
and pNZ7023 were found to accumulate pools of 7.8 and 5.3
mg of pABA/liter, respectively, per OD600 unit in the cell
extract. An equivalent amount of pABA was found to be
produced by strain NZ9000pABA containing pNZ7022
(5.3 mg/liter per OD600 unit). Assuming complete retention
of pABA and an intracellular volume of 3.6 l/mg cell pro-
tein (an OD600 value of 1 corresponds with 0.2 mg cell
protein per ml) (28), the intracellular pABA pool reaches a
size of 57 to 84 mM. In conclusion, overexpression of the
pabA-pabBC genes in L. lactis resulted in a high intracellu-
lar accumulation of pABA, proving their involvement in the
biosynthesis of pABA.
Overexpression of folate and pABA. Overexpression of the
pABA gene cluster in strain NZ9000pABA boosted the
pABA production but did not lead to elevated folate pools.
Sybesma (38) has shown that pABA biosynthesis controls the
overproduction of folate in a strain which overexpresses the
entire folate gene cluster. We hypothesize that the expression
of the pteridine pathway and that of the pABA pathway are
tightly coupled. In previous work (38), an L. lactis strain
(NZ9000 containing the pNZ7019 vector) that produces high
folate levels was constructed; the folate biosynthesis genes
(folB, folKE, folP, folQ, and folC) were cloned on a high-copy-
number vector (pNZ8148 derivative) under the control of the
pepN promoter. This strain was cultivated in CDM in the
presence and absence of pABA. Only when pABA was sup-
plied to the medium were high folate levels (2.3 mg/liter per
OD600 unit) found to be produced. In the absence of pABA, no
elevated folate levels were observed (Fig. 4.). Vector pNZ7023
(pIL253 derivative), containing the pabA-pabBC gene cluster
under the control of the nisin promoter, was transferred to
competent cells of L. lactis NZ9000 harboring pNZ7019. The
resulting strain, named L. lactis NZ7024, was cultivated on
CDM without pABA. Interestingly, after nisin induction, this
FIG. 3. Folate production (g/ml per OD600 unit) of the L. lactis wild-type strain (wt) harboring pNZ8148 (empty vector) and pNZ7020
(nisin-inducible pABA overexpression vector). The folate pool quantities of intracellular, extracellular, and total fractions are shown. The
uninduced folate levels are depicted in gray bars, and the induced folate levels are shown in black.
FIG. 4. Total folate production levels (mg/liter per OD600 unit) of
three different strains: L. lactis NZ9000 (wild type [wt]), L. lactis
NZ9000 harboring pNZ7019 (folate overexpression vector) cultivated
in the presence and absence of pABA, and L. lactis NZ7024 (NZ9000
strain harboring the folate and pABA overexpression vector) culti-
vated without pABA prior to and after the induction with nisin.
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strain was able to produce 2.7 mg of folate/liter per OD600 unit,
independently of pABA supplementation of the growth me-
dium (Fig. 4). Without induction, only 0.4 mg of folate/liter per
OD600 unit was produced. In the L. lactis NZ7024 strain, the
expression of the pABA gene cluster results in the conversion
of chorismate into high pABA levels. Simultaneously, the over-
expression of the folate gene cluster leads to the conversion of
GTP into THF, which can be achieved only when high pABA
levels are present. Therefore, we conclude that the overexpres-
sion of the pABA genes combined with the overexpression of
the folate biosynthesis genes is essential for the overproduction
of folate. The overexpression of only pABA or the folate gene
cluster separately cannot boost folate production.
DISCUSSION
Based on the observation in a previous study that L. lactis
MG1363 is capable of producing folate (41), it was expected
that all genes for the synthesis of pABA are present in L. lactis.
And indeed after bioinformatics analysis it was found that L.
lactis IL-1403 (3), a strain closely related to L. lactis MG1363,
possesses the three genes needed for pABA production. L.
lactis MG1363 contains pabA as a separate open reading frame
and pabBC as a fused open reading frame. These merged
pabBC genes were found not only in L. lactis but also in other
gram-positive bacteria as well as in several gram-negative bac-
teria, suggesting that this gene fusion was the result of an
ancient event. Another interesting feature of the pABA genes
is the homology they share with the genes for tryptophan
biosynthesis. The pabA gene is homologous with the trpG gene,
and pabB is homologous with trpE (23). However, no pabC
homologue has been found, suggesting that pabC is very spe-
cific for converting 4-amino-4-deoxychorismate into pABA. In
the tryptophan biosynthesis pathway, chorismate is converted
via TrpE and TrpG into 2-ABA (anthranilate), whereas in the
pABA biosynthesis pathway, chorismate is converted via PabA,
PabB, and PabC into 4-ABA (pABA). The facts that two en-
zymes are required to produce 2-ABA and that three enzymes
are needed for the synthesis of pABA highlight the important
role of PabC and the crucial difference between the tryptophan
and the pABA biosynthesis pathway.
The pABA biosynthetic enzymes (PabA, PabB, and PabC)
play an important role in the biosynthesis of folate. The dele-
tion of the pabA-pabBC gene cluster in L. lactis led to a strain
that was unable to grow in the absence of pABA, glycine,
serine, and nucleobases/nucleosides. Adding all nucleobases/
nucleosides to the medium restored the growth of strain
NZ9000pABA completely but did not restore folate produc-
tion. It was demonstrated that single additions of purines to
the spent medium restored the growth of the NZ9000pABA
strain. From this it can be concluded that the addition of
purines circumvents the requirement for folate as a cofactor
for the synthesis of IMP. Purines are synthesized from 5-phos-
pho-D-ribosyl-1-pyrophosphate via several steps into IMP (14).
In this biosynthetic pathway, 10-formyltetrahydrofolate is used
twice as a cofactor, showing the key role of 10-formyltetrahy-
drofolate in the formation of purines. But the role of 5,10-
methylenetetrahydrofolate is not so clear for both the conver-
sion of dUMP to dTMP and the conversion of glycine to
serine. Glycine, serine, and pyrimidines can be omitted from
the medium, and still the NZ9000pABA strain is able to
grow, providing the presence of purines in the medium. This
demonstrates that the pyrimidine biosynthesis pathway seems
to operate in the absence of 5,10-methylenetetrahydrofolate.
This raises the question of which cofactor, other than folate, is
used by thymidylate synthase (EC 2.1.1.45) for the conversion
of dUMP to dTMP. However, the complex defined medium
contains components that can circumvent the necessity of 5,10-
methylenetetrahydrofolate as a cofactor for the glycine-serine
interconversion. From the model of the metabolic network of
L. plantarum WCFS1 (44), it could be deduced that threonine
can be converted into glycine via threonine aldolase (EC
4.1.2.5.). In addition, the reconstructed metabolic network also
predicts that cysteine can be converted into serine by cysteine
synthetase (EC 4.2.99.8) and serine O-acetyltransferase (EC
2.3.1.30). In a similar experiment, the inhibitory effect of anti-
folates like methotrexate and trimethoprim can also be coun-
teracted by the addition of the end products of folate biosyn-
thesis (1, 12). These antifolates compete with folate in the cell
for the enzyme dihydrofolate reductase (EC 1.5.1.3.), thereby
depleting the folate pool which serves as the cofactor in the
nucleotide biosynthesis pathway.
One other interesting feature of the medium depletion ex-
periments is the fact that somehow protein translation is ini-
tiated in the absence of folate. This was previously investigated
in S. faecalis R by Samuel et al. (33), who suggested that there
might be an alternative C1 donor for the initiation of protein
synthesis or that no formylation is needed to initiate transla-
tion in S. faecalis R.
Overexpression of the pABA gene cluster on three different
vectors, namely, two nisin-inducible vectors (pNZ7020 and
pNZ7023) and one constitutive vector (pNZ7022), led to the
accumulation of pABA. The overproduction of pABA, how-
ever, did not lead to elevated folate pools. This confirms earlier
results of Sybesma (38), who demonstrated that folate levels
could not be increased solely by the overexpression of the
folate biosynthesis genes of L. lactis. Hence, we constructed a
strain (L. lactis NZ7024) overexpressing the pABA and the
folate biosynthesis gene clusters simultaneously. This strain
was found to produce high folate levels independently of
pABA supplementation.
Although overproduction of pABA alone did not result in
elevated (total) folate pools, we observed a shift in the folate
distribution across the cytoplasmic membrane (accumulated
versus secreted folate). The overproduction of pABA leads to
relatively low intracellular folate pools and a relatively high
secretion of folate. An explanation for this phenomenon is that
elevated pABA pools might inhibit the activity of the enzyme
responsible for the elongation of the polyglutamate tail of the
folate molecule folylpolyglutamate synthetase. It is known that
monoglutamate THF molecules diffuse more readily out of the
cell than the more highly charged polyglutamate THF deri-
vates (19, 22, 34). In L. lactis, it was found that overexpression
of the gene coding for folylpolyglutamate synthetase (folC)
resulted in increased polyglutamate tails, which caused higher
intracellular retention (42).
The observation that folate production was already restored
in the pABA KO strain without nisin induction suggests that
the inducible nisin promoter in the vectors pNZ7020 and
pNZ7023 exhibited a low but significant activity in the absence
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of its inducer molecule (nisin). As a result, the wild-type phe-
notype is restored in the absence of the inducer nisin. The use
of high- and intermediate-copy-number plasmids, such as
pNZ7020 and pNZ7023, respectively, can amplify the effect of
low promoter activity, resulting in the restoration of the wild-
type phenotype.
This study shows that the activities of the pathways for folate
and pABA biosynthesis in L. lactis are tightly correlated. First,
the deletion of the pABA genes in L. lactis eliminated its ability
to synthesize folate, causing a complete inability to grow in the
absence of purine nucleobases/nucleosides. In the presence of
purine nucleobases/nucleosides, folate is not required for
growth. Furthermore, we have shown that folate is not strictly
required for the pyrimidine biosynthesis pathway. The over-
production of folate or pABA alone did not result in a strain
with increased folate pools. However, the combined overex-
pression of folate and pABA biosynthesis pathways led to a
strain that produces a high folate concentration and that does
not rely on the supplementation of precursors in the medium.
This strongly suggests that in the wild-type cells, the produc-
tion of pABA and 2-amino-4-hydroxy-6-hydroxymethyl-7,8-di-
hydropteridine (the intermediate of the folate biosynthesis
pathway at the pABA junction) are tightly correlated. In fact,
both pathways need to be overexpressed simultaneously to
increase total folate pools 80-fold in the absence of an external
pABA source.
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